methotrexate has been researched along with Extravascular Hemolysis in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (37.84) | 18.7374 |
| 1990's | 2 (5.41) | 18.2507 |
| 2000's | 3 (8.11) | 29.6817 |
| 2010's | 16 (43.24) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso-Castro, AJ; Campos-Xolalpa, N; Hernández-Munive, A; Pérez-González, C; Pérez-Gutiérrez, S; Zapata-Morales, JR | 1 |
| Choudhary, S; Kaur Bhatia, J; Kumar, V; Mankotia, P; Parmar, A; Sharma, K; Sharma, S; Sharma, V | 1 |
| Adabi, M; Bergonzi, MC; Esnaashari, SS; Khosravani, M; Madani, F; Webster, TJ; Younes, HM | 1 |
| Dora, CP; Jain, S; Katiyar, SS; Kushwah, V | 1 |
| Ghorbani, M; Jannat, B; Mahmoodzadeh, F | 1 |
| Koul, V; Kumar Dinda, A; Kumar, A; Naz, F | 1 |
| Chamundeeswari, M; Muthukumar, T; Prabhavathi, S; Sastry, TP | 1 |
| Chamundeeswari, M; Chandhuru, J; Gurunathan, B; Muthukumar, T; Prabhavathi, S; Sastry, TP | 1 |
| Gupta, U; Hira, SK; Manna, PP; Misra, N; Mitra, K; Ramesh, K; Ray, B | 1 |
| Dey, S; Rekha, MR; Sherly, MC; Sreenivasan, K | 1 |
| Athawale, RB; Bajaj, AN; Goel, PN; Gude, RP; Jain, DS; Pandey, A; Patil, S; Raut, P; Shikhande, SS | 1 |
| Ahmed, W; Ghafoor, S; Muhammad, Z; Naeem, A; Naz, SS; Rana, NF; Raza, A; Riaz, S | 1 |
| Hyun, S; Kim, S; Lee, Y; Yu, J | 1 |
| Jiang, YY; Kong, SY; Pei, YY; Tang, GT; Zhang, LH; Zhu, SJ | 1 |
| Gajbhiye, V; Jain, NK; Kayat, J; Kurmi, BD | 1 |
| Bovin, NV; Grandfils, C; Kuznetsova, NR; Lespineux, D; Mészáros, T; Sevrin, C; Szebeni, J; Vodovozova, EL | 1 |
| Durgadas, CV; Sharma, CP; Sreenivasan, K | 1 |
| Kundu, SC; Subia, B | 1 |
| Fischer, G; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Lechner, K; Mayr, W; Mitterbauer, M; Worel, N | 1 |
| Benson, DM; Blum, W; Grady, T; Kennedy, MS; Krugh, D; Marcucci, G; O'Donnell, L; Williams, JD | 1 |
| Borsos, T; Circolo, A | 2 |
| Kato, Y; Langone, JJ; Paterson, A | 1 |
| Borsos, T; Dunkel, VC; Langone, JJ | 1 |
| Borsos, T; Chapuis, RM; Langone, JJ | 1 |
| Brugger, S; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Knöbl, P; Kyrle, PA; Linkesch, W; Schneider, B; Schwarzinger, I | 1 |
| Conn, JS; Fitzgerald, JM; Jackson, GH; Proctor, SJ; Tiplady, CW | 1 |
| Esser, B; Pilwat, G; Zimmermann, U | 1 |
| Bertino, JR; Cadman, EC; Lunberg, WB | 1 |
| Calhoun, L; Champlin, RE; Gajewski, JL; Ho, WG; Hunt, LA; Landaw, EM; Lyddane, NR; O'Rourke, S; Petz, LD; Schiller, GJ | 1 |
| Battista, P; Borsos, T; Circolo, A | 1 |
| Borsos, T; Kirschfink, M | 1 |
| Baldeschwieler, JD; Freehauf, CL; Kruse, CA; Patel, KR | 1 |
| Ihler, GM; Tsang, HC | 1 |
| Bodourian, SH; Pesce, MA | 1 |
| Hennigar, GR | 1 |
| Byfield, P; Sercarz, E | 1 |
1 review(s) available for methotrexate and Extravascular Hemolysis
| Article | Year |
|---|---|
Erythrocyte carriers.
Topics: Amphotericin B; Anemia, Sickle Cell; Animals; Cytarabine; Daunorubicin; Erythrocyte Deformability; Erythrocyte Membrane; Erythrocytes; Excipients; Glucosylceramidase; Glucuronidase; Hemolysis; Humans; Methotrexate; Molecular Weight; Phagocytosis; Pharmaceutical Preparations | 1985 |
36 other study(ies) available for methotrexate and Extravascular Hemolysis
| Article | Year |
|---|---|
Synthesis, antinociceptive and anti-inflammatory effects of porphyrins.
Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Disease Models, Animal; Edema; Erythrocytes; Hemolysis; Indomethacin; Male; Mice; Naproxen; Nociception; Pain; Pain Measurement; Porphyrins; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate | 2015 |
Neem gum based pH responsive hydrogel matrix: A new pharmaceutical excipient for the sustained release of anticancer drug.
Topics: Antineoplastic Agents; Azadirachta; Biocompatible Materials; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Excipients; Hemolysis; Humans; Hydrogels; Hydrogen-Ion Concentration; Methotrexate; Microwaves; Plant Extracts; Plant Gums; Polymerization; Solubility; Solvents | 2020 |
Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Topics: Animals; Antineoplastic Agents; Apolipoproteins; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Drug Compounding; Drug Liberation; Endocytosis; Glioblastoma; Hemolysis; Humans; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Methotrexate; Nanoparticles; Paclitaxel; Polylactic Acid-Polyglycolic Acid Copolymer; Proto-Oncogene Proteins c-bcl-2; Rats | 2020 |
Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Cell Survival; Delayed-Action Preparations; Drug Liberation; Erythrocytes; Female; Hemolysis; Humans; Lipids; MCF-7 Cells; Methotrexate; Mice; Nanoparticles; Neoplasms; Rats, Sprague-Dawley; Surface-Active Agents; Tumor Burden; Valine | 2019 |
Chitosan-based nanomicelle as a novel platform for targeted delivery of methotrexate.
Topics: A549 Cells; Cell Survival; Chitosan; Drug Delivery Systems; Drug Liberation; Endocytosis; Fluorescein; Hemolysis; Humans; MCF-7 Cells; Methotrexate; Micelles; Nanoparticles; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared | 2019 |
Investigation of ultrafine gold nanoparticles (AuNPs) based nanoformulation as single conjugates target delivery for improved methotrexate chemotherapy in breast cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Blood Coagulation; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Survival; Drug Carriers; Erythrocytes; Female; Gold; Hemolysis; Hep G2 Cells; Humans; MCF-7 Cells; Metal Nanoparticles; Methotrexate; Mice; Tumor Burden | 2019 |
Bio-modified carbon nanoparticles loaded with methotrexate possible carrier for anticancer drug delivery.
Topics: Animals; Antineoplastic Agents; Carbon; Cattle; Cell Death; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Hemolysis; Humans; Methotrexate; Microscopy, Atomic Force; Nanoparticles; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thermogravimetry; X-Ray Diffraction | 2014 |
Carbon nanoparticle from a natural source fabricated for folate receptor targeting, imaging and drug delivery application in A549 lung cancer cells.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Asparaginase; Carbon; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Folic Acid Transporters; Hemolysis; Humans; Methotrexate; Mice; Microscopy, Atomic Force; Nanocomposites; Nanoparticles; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2014 |
Methotrexate-Loaded Four-Arm Star Amphiphilic Block Copolymer Elicits CD8+ T Cell Response against a Highly Aggressive and Metastatic Experimental Lymphoma.
Topics: Adaptive Immunity; Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Erythrocytes; Hemolysis; Humans; Kaplan-Meier Estimate; Lymphoma; Methotrexate; Mice; Mice, Inbred AKR; Micelles; Neoplasm Metastasis; Polymers; Pyrenes; Transplantation, Heterologous | 2015 |
Alginate stabilized gold nanoparticle as multidrug carrier: Evaluation of cellular interactions and hemolytic potential.
Topics: Alginates; Animals; Biological Transport; Curcumin; Drug Carriers; Drug Stability; Glucuronic Acid; Gold; Hemolysis; Hexuronic Acids; Humans; MCF-7 Cells; Metal Nanoparticles; Methotrexate; Rats | 2016 |
Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route.
Topics: Administration, Intranasal; Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Drug Carriers; Drug Compounding; Erythrocytes; Half-Life; Hemolysis; Humans; Methotrexate; Nanoparticles; Nasal Mucosa; Particle Size; Poloxamer; Polyesters; Rats; Rats, Wistar | 2016 |
PEG capped methotrexate silver nanoparticles for efficient anticancer activity and biocompatibility.
Topics: Antineoplastic Agents; Cell Survival; Drug Carriers; Erythrocytes; Female; Hemolysis; Humans; MCF-7 Cells; Metal Nanoparticles; Methotrexate; Polyethylene Glycols; Silver | 2016 |
Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability.
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Cations; Cell Membrane; Cell Survival; Cell-Penetrating Peptides; Drug Delivery Systems; Female; Glutamine; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Lysine; Methotrexate; Mutation; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dendrimers; Drug Carriers; Female; Hemolysis; Humans; Magnetic Resonance Spectroscopy; Male; Methotrexate; Mice; Polyethylene Glycols; Rats; Rats, Sprague-Dawley | 2010 |
Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate.
Topics: Animals; Antimetabolites, Antineoplastic; Cells, Cultured; Dendrimers; Drug Carriers; Erythrocytes; Female; Hemolysis; Humans; Lactoferrin; Lung; Male; Methotrexate; Microscopy, Electron, Transmission; Nanocomposites; Polypropylenes; Rats; Rats, Sprague-Dawley; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tissue Distribution | 2011 |
Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer.
Topics: Animals; Blood Coagulation; Blood Platelets; Complement Activation; Dose-Response Relationship, Drug; Erythrocytes; Hemolysis; Humans; In Vitro Techniques; Lipid Bilayers; Liposomes; Melphalan; Methotrexate; Nanoparticles; Particle Size; Phosphatidylcholines; Phosphatidylinositols; Prodrugs; Surface Properties | 2012 |
Bright blue emitting CuSe/ZnS/silica core/shell/shell quantum dots and their biocompatibility.
Topics: Biocompatible Materials; Cell Aggregation; Cell Death; Complement Activation; Drug Delivery Systems; Hemolysis; Hep G2 Cells; Humans; Light; Methotrexate; Microscopy, Fluorescence; Nanoparticles; Neoplasms; Platelet Factor 4; Quantum Dots; Selenium Compounds; Silicon Dioxide; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Sulfides; Zinc Compounds | 2012 |
Drug loading and release on tumor cells using silk fibroin-albumin nanoparticles as carriers.
Topics: Animals; Antimetabolites, Antineoplastic; Bombyx; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Survival; Drug Carriers; Female; Fibroins; Hemolysis; Humans; Methotrexate; Nanoparticles; Particle Size; Serum Albumin; Spectroscopy, Fourier Transform Infrared | 2013 |
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
Topics: ABO Blood-Group System; Adolescent; Adult; Aged; Anemia, Hemolytic; B-Lymphocytes; Blood Group Incompatibility; Carcinoma, Renal Cell; Erythrocyte Transfusion; Female; Graft vs Host Disease; Hematologic Neoplasms; Hemolysis; Humans; Immunosuppressive Agents; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Peripheral Blood Stem Cell Transplantation; Prevalence; Rh-Hr Blood-Group System; Survival Analysis; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous | 2002 |
Successful management of sudden, massive immune hemolysis following ABO-incompatible allogeneic PBSCT despite methotrexate GvHD prophylaxis.
Topics: ABO Blood-Group System; Adult; B-Lymphocytes; Benzamides; Blood Group Incompatibility; Graft vs Host Disease; Hemolysis; Humans; Imatinib Mesylate; Immunosuppressive Agents; Male; Methotrexate; Piperazines; Pyrimidines; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Treatment Outcome | 2005 |
Lysis of sheep red cells in neat autologous serum as a source of antibody and complement.
Topics: Animals; Antibodies; Complement System Proteins; Erythrocytes; Haptens; Hemolysis; Immunoglobulin M; In Vitro Techniques; Methotrexate; Sheep; Species Specificity | 1984 |
Monoclonal antibodies to the chemotherapeutic agent methotrexate: production, properties and comparison with polyclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Antigens; Ascitic Fluid; Binding, Competitive; Female; Goats; Hemocyanins; Hemolysis; Hybridomas; Immunoglobulin G; Methotrexate; Mice; Mice, Inbred BALB C; Rabbits; Radioimmunoassay; Staphylococcal Protein A | 1984 |
Immunoassay of antigens and haptens by inhibition of passive immune hemolysis.
Topics: Animals; Antibody Specificity; Antigen-Antibody Complex; Antigens; Complement Fixation Tests; Cross Reactions; Dose-Response Relationship, Immunologic; Erythrocytes; Haptens; Hemolysis; Immunization; Kinetics; Leucovorin; Methotrexate; Rabbits | 1980 |
Distinction between fixation of C1 and the activation of complement by natural IgM anti-hapten antibody: effect of cell surface hapten density.
Topics: Complement Activation; Complement C1; Complement Fixation Tests; Dose-Response Relationship, Immunologic; Haptens; Hemolysis; Humans; Immunoglobulin M; Leucovorin; Methotrexate | 1981 |
Lysis of hapten-labeled cells by anti-hapten IgG and complement: effect of cell surface hapten density.
Topics: Animals; Binding Sites, Antibody; Cell Membrane; Complement System Proteins; Haptens; Hemolysis; Immunoglobulin G; Methotrexate; Protein Conformation; Rabbits; Sheep | 1982 |
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemolysis; Humans; Hypertension; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Methotrexate; Methylprednisolone; Middle Aged; Nervous System Diseases; Plasmapheresis; Platelet Count; Retrospective Studies; Syndrome; Transplantation, Homologous; Vascular Diseases | 1995 |
Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant.
Topics: ABO Blood-Group System; Adult; B-Lymphocytes; Blood Cells; Blood Donors; Blood Group Incompatibility; Hematopoietic Stem Cell Transplantation; Hemolysis; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rh-Hr Blood-Group System; Transplantation Immunology; Transplantation, Homologous | 2001 |
The effect of encapsulation in red blood cells on the distribution of methotrexate in mice.
Topics: Animals; Erythrocyte Membrane; Erythrocytes; Hemolysis; Humans; Kinetics; Methotrexate; Mice; Tissue Distribution | 1978 |
Hyperphosphatermia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt's lymphoma and Burkitt cell leukemia.
Topics: Acute Kidney Injury; Adult; Burkitt Lymphoma; Cyclophosphamide; Head and Neck Neoplasms; Hemolysis; Humans; Hypocalcemia; Leukemia; Male; Methotrexate; Phosphorus; Uric Acid | 1977 |
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Topics: ABO Blood-Group System; Adult; Anemia, Aplastic; Antibodies; Blood Component Transfusion; Blood Group Incompatibility; Bone Marrow Transplantation; Coombs Test; Cyclosporine; Hemolysis; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 1992 |
Activation of hemolytic complement by mouse monoclonal IgG1 antibody: comparison with rabbit IgG.
Topics: Animals; Antibodies, Monoclonal; Complement Activation; Complement C1; Dose-Response Relationship, Immunologic; Epitopes; Haptens; Hemolysis; Immunoglobulin G; Methotrexate; Mice; Rabbits; Staphylococcal Protein A | 1985 |
Augmentation of hemolytic efficiency of anti-hapten IgG antibody by anti-IgG antibody is primarily the function of the anti-hapten IgG.
Topics: Animals; Antibodies, Anti-Idiotypic; Complement System Proteins; Forssman Antigen; Haptens; Hemolysis; Immunoglobulin G; Leucovorin; Methotrexate; Rabbits | 1987 |
Mouse erythrocyte carriers osmotically loaded with methotrexate.
Topics: Animals; Erythrocyte Membrane; Erythrocytes; Half-Life; Hemolysis; Humans; Kinetics; Liver Neoplasms, Experimental; Methotrexate; Mice; Tissue Distribution | 1987 |
Evaluation of a fluorescence polarization immunoassay procedure for quantitation of methotrexate.
Topics: Bilirubin; Cross Reactions; Hemolysis; Humans; Immunoassay; Indicators and Reagents; Lipids; Methotrexate; Monitoring, Physiologic; Spectrometry, Fluorescence | 1986 |
Iatrogenic drug toxicity.
Topics: Acetaminophen; Age Factors; Amphotericin B; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Hemolysis; Humans; Isoniazid; Kidney Diseases; Methotrexate; Pharmaceutical Preparations; Probability; Time Factors | 1985 |
The X-Y-Z scheme of immunocyte maturation. VII. Cell division and the establishment of short-term IgM memory.
Topics: Animals; Antigen-Antibody Reactions; Antigens; Cell Division; Erythrocytes; Female; Hemolysis; Hydroxyurea; Immune Tolerance; Immunoglobulin M; Injections, Intraperitoneal; Leucovorin; Male; Methods; Methotrexate; Mice; Spleen; Time Factors | 1969 |